StartupsFinSMEsabout 4 hours ago
SpliSense Raises Up to $13M in Funding
1 min read
SpliSense raised up to $13 million in funding. The company secured the capital to advance its pipeline of RNA-based therapies. SpliSense focuses on developing treatments for cystic fibrosis and other genetic lung diseases.
Level
Hype check
Tap to vote and see what everyone thinks.
